Search results

153 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Commentary: Current evidence does not support call for more frequent colorectal cancer screening
In an editorial published in JAMA, UNC Lineberger's Hanna Sanoff, MD, MPH, evaluated two studies that investigated whether higher-intensity testing for non-metastatic colorectal cancer is more effective.
Located in News
Basch receives $5.45M grant to study patient-reported outcomes
Ethan Basch, MD, MSc, will use a five-year, $5.45 million grant from the Patient-Centered Outcomes Research Institute to support his national study on whether having cancer patients self-report their symptoms while undergoing treatment results in better care.
Located in News
Chen awarded $11.9 million grant to study radiation treatments for prostate cancer
Ronald C. Chen, MD, MPH, will use the PCORI grant to conduct national comparative study of intensity-modulated radiation therapy and proton beam for prostate cancer.
Located in News
Mayer advising NCI on cancer survivorship issues and research
UNC Lineberger's Deborah K. Mayer, PhD, RN, AOCN, FAAN, will continue to work at UNC-Chapel Hill while providing counsel to the National Cancer Institute’s Division of Cancer Control and Population Sciences on issues related to cancer survivorship.
Located in News
Shelley Golden
Shelley Golden, MPH, PhD, is a UNC Lineberger Comprehensive Cancer Center member and a Clinical Assistant Professor of Health Behavior in the UNC-Chapel Hill Gillings School of Global Public Health.
Located in People / Profiles
Arlene Chung
Arlene Chung, MD, MHA, MMCi is a UNC Lineberger Comprehensive Cancer Center member, an Assistant Professor of Medicine and Pediatrics and Associate Director of Health and Clinical Informatics for the UNC School of Medicine.
Located in People / Profiles
Located in Newsroom / UNC Lineberger in the News
Cancer drug parity laws lower costs for many, but not everyone
In an analysis of the impact of parity laws published in JAMA Oncology, UNC Lineberger researchers led by Stacie Dusetzina, PhD, and collaborators from Harvard Medical School report modest improvements in costs for many patients. However, patients who were already paying the most for their medications, saw their monthly costs go up.
Located in News